Express Pharma
Home  »  Latest Updates  »  CII and Novo Nordisk India organise India Innovation Dialogue

CII and Novo Nordisk India organise India Innovation Dialogue

Read Article

Deliberations were held on ‘Exploring the next decade of Indian innovation’

The Confederation of Indian Industry (CII) in association with Novo Nordisk India and Royal Embassy of Denmark organised the India Innovation Dialogue in New Delhi. Attended by over 100 corporate leaders, government representatives and media, the India Innovation Dialogue provided the platform for innovation leaders to deliberate on ‘Exploring the next decade of Indian Innovation.’

Lars Rebien Sorensen, President and CEO, Novo Nordisk, Rakesh Bharti Mittal, Vice President, Confederation of Indian Industry & Vice-Chairman, Bharti Enterprises, TV Narendran, MD, Tata Steel and Bhasker V Iyer, Non-Executive Director, Abbott India were among the notable attendees. The roundtable was moderated by Ajoy Kumar, ex-member of Parliament.

The round table saw participation from leading policy makers, global CEOs, experts in social and grassroots innovation, and well known economists. The panellists engaged in insightful discussions on possibilities of improving industrial innovation landscape for sustainable value creation in India over the coming decade, commercialisation of grass-root innovations, facilitating start-ups, strategies to impact innovation, and how to leverage strength of networking with government, industry, institutions and academia.

Sorensen who was one of the panellists said, “India is a great land of innovation and ingenuity. As industry leaders, we have the means and resources to develop ideas into action for the betterment of the society. This is what innovation is. But innovation simply cannot sustain on dreams alone, a commitment too is required. For us at Novo Nordisk, innovation is in the foundation of our existence and it is what drives us to help people with diabetes lead normal life and pursue their dreams. We do this by forging a partnership with the various stakeholders to work together to defeat diabetes. In India, the Novo Nordisk Education Foundation too is collaborating with several state governments and organisations in order to reach out to people to enhance awareness and train healthcare professionals.”

Representing the industry Mittal said “Only choice for the survival of Indian industry is to re-imagine Indian innovation. India needs to boost its innovation ecosystem, which is only possible if we contribute our part in this journey.”

Narendran said, “We cannot work in isolation, and all stakeholders must come and work together to achieve success in the long run.”

From World Intellectual Property Organization (WIPO) Dr. Sacha Wunsch Vincent said, “Innovation is in the Indian DNA. While world economy is slowing down, India’s position is positive and their global innovation index ranking has improved.”

EP News BureauMumbai

Comments are closed.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Know Importance of using different levels of Controls
Register Now!